REFERENCIAS BIBLIOGRÁFICAS
1. Parrish JA, White HAD, Patak W. Fotomedicina. En: Fitzpatrick TB. Dermatología en Medicina General. Buenos Aires: Editorial Médica Panamericana. Segunda edición. pp. 982-1019.
2. Simon JC, Pfleger D, Schopf E. Recent advances in phototherapy. Eur J Dermatol 2000; 10: 642-5.
3. Parrish A, Jaenicke KF. Erythema and Melanogenesis action spectra in normal human skin. Photochem Photobiol 1982; 36:
187-90.
4. Khurshid K, Haroon TS, Hussain y Col. Psoralen-ultraviolet A therapy vs.
Psolarem-ultraviolet B therapy in the treatment of plaque-type psoriasis: our experience with Fitzpatrick skin type IV Int J Dermatol 2000; 39: 865-7.
5. Clew NB. Determination of 8 Methoxypsolaren in Serum Aquous and Lens. Relation to Long
- Wave Ultraviolet Phototoxixity. In Experimental and Clinical Photochemotherapy. Trans Am Ophthalmol Soc 1979; 77:
464-8.
6. Epstein JH, et al. Current status of oral PUVA therapy. J Am Acad Dermatol 1979; 1:
106-9.
7. Mc Evoy MT, Stern RS. Psoralens and related compounds in the treatment of
psoriasis. Pharmacol Ther 1987; 34: 75-97.
8. Krutmann J, Czceh W Diepgen T, et al. High dose UVA-I therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatology 1992; 26:
225-30.
9. Krutmann J, Diepgen T, Luger TA, et al. High dose UVA-I Therapy for atopic dermatitis: Result of a multicenter trial. J Am Acad Dermatol 1998; 38:
589-93.
10. Stege S, Berneburg M, Humkes, et al. High dose UVA-I radiation therapy for localized scleroderma. J AmAcad Dermatol 1997;
36: 958.
11. Ketscherm D, Volikenandt M. Treatment of localized scleroderma by UVA-I
phototherapy. Lancet 1995; 346: 1166.
12. Herrmann JJ, Roenigk HH, Huria A. Treatment of Mycosis Fungoide with
photochemotherapy PUVA. J Am Acad Dermatol 1995; 33: 234-242.
13. Schempp Ch, Muller H, Czech W, et al. Treatment of chronic palmoplantar eczema with local PUVA Therapy. J Am Acad Dermatol 1997; 36:
733-7.
14. Storbeck K, Hozle E, Lehmann P, et al. Die Wirksamkeit Eines neuen Schmalspektrurn
- UV-B B-Strahlers (Phillips TL 01 100W 311 nm) im Vergleinch Zur Konventionellen
UV-B Photetherapie der Psoriasis. Z Hautkr 1991; 66: 708-12.
15. Green E, Hakshmipathi T, Johnson BE, et al. A comparison of the efficiency and relapse rates of narrow band UVB
(TL-01) Monotherapy Vs. Etretinate-PUVA (REPUVA) in the treatment of psoriasis patients. Br J Dermatol 1992; 127:
5-9.
16. Bargallo J, Spann CT, Tutrone WD. Narrow band UVB phototherapy for the treatment of psoriasis: a review and update. Cutis. 2001; 68:
345-7.
17. Price NM, et al: Topical mechlorethamine therapy for mycosis fungoides. Br J Dermatol 1977, 97:
547-550.
18. Weinstein G, et al. Psoriasis - LIVER - Methotrexate interactions. Arch Dermatol 1973; 108: 36.
19. Roemigk HH, et al. Methotrexate therapy of psoriasis. Guideline revision. Arch Dermatol 1973; 108: 35.
20. Limdelof B, Sigurgeirsso R, Tegner E. PUVA and cancer risk. Br J Dermatol 1999;
141: 108 -12
21. Zanolli M, Feldman S, Clark A, Fleicher A Jr. Phitotherapy, treatment protocols for psoriasis and others phototerapy responsive dermatosis. New York: The Parthenon
Group, 2000.
